Healthcare Services

Rising Chronic Disease Burden Driving Demand For Early Detection And Preventive Care Supporting Medical Health Screening Market Growth

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Medical Health Screening Market Expected To Change From 2026 To 2030?

The medical health screening market has experienced robust growth over recent years. Projections indicate it will expand from $19.74 billion in 2025 to $21.06 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by increasing awareness of preventive healthcare, the expansion of diagnostic laboratory networks, the rising prevalence of chronic diseases, improved access to routine testing services, and the growth of employer-sponsored health programs.

The medical health screening market size is poised for robust expansion in the next few years, projected to grow to $26.97 billion by 2030 at a compound annual growth rate (CAGR) of 6.4%. This growth during the forecast period is attributed to the increasing adoption of personalized medicine approaches, the rising integration of digital health platforms, the expansion of population-level screening initiatives, a growing demand for home-based testing services, and an increasing focus on early cancer detection. Major trends expected in this period include the increasing adoption of preventive health screening programs, a rising use of multi-parameter diagnostic panels, a growing demand for early disease detection services, the expansion of corporate and occupational health screening, and an enhanced focus on personalized screening protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25824&type=smp

Which Key Factors Are Driving The Medical Health Screening Market Growth?

An anticipated increase in chronic disease cases is set to boost the expansion of the medical health screening market. These conditions are defined as persistent health issues, including diabetes, heart disease, and asthma, typically lasting at least a year, necessitating ongoing medical attention or impacting daily activities. Sedentary lifestyles are contributing to the growing incidence of chronic diseases, with extended periods of inactivity undermining general health and making individuals more susceptible to lasting medical problems. Medical health screening offers significant benefits for chronic diseases by facilitating the prompt detection of risk factors and early symptoms. This enables swift intervention and effective management, thereby preventing complications, enhancing the quality of life, and lessening the overall impact of these enduring conditions. For example, the International Diabetes Federation, a Belgium-based non-profit organization, reported in April 2025 that 589 million adults aged 20–79 globally are currently affected by diabetes, with projections indicating an increase to 853 million by 2050. Consequently, the expanding occurrence of chronic diseases is a key factor propelling the growth of the medical health screening market.

What Segment Categories Shape The Medical Health Screening Market Segment Landscape?

The medical health screening market covered in this report is segmented –

1) By Test Type: Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, Other Test Types

2) By Sample Type: Blood, Urine, Saliva, Other Sample Types

3) By End User: Hospitals Or Clinics, Diagnostic Laboratories, Workplaces, Research Institutes, Other End Users

Subsegments:

1) By Routine Tests: Blood Pressure Monitoring, Blood Glucose Testing, Lipid Profile, Complete Blood Count (CBC), Urinalysis

2) By Non-Routine Tests: Genetic Testing, Hormonal Testing, Allergy Testing, Infectious Disease Testing

3) By Cancer Screening Tests: Mammography, Pap Smear Test, Colonoscopy, Prostate-Specific Antigen (PSA) Test, Low-Dose CT Scan For Lung Cancer

4) By Specialty Tests: Cardiovascular Screening, Neurological Screening, Pulmonary Function Tests, Bone Density Test

5) By Other Test Types: Wellness Tests, Executive Health Checkups, Prenatal Screening, Occupational Health Screening

Which Trends Are Guiding The Direction Of The Medical Health Screening Market?

Major companies operating in the medical health screening market are focusing on introducing advanced solutions, such as artificial intelligence-powered radiology informatics and cancer screening, with the goal of enhancing early detection, improving diagnostic accuracy, and streamlining clinical workflows. AI-powered radiology informatics and cancer screening involve utilizing artificial intelligence technologies to analyze medical imaging data, enabling the identification of potential signs of cancer or other abnormalities with increased speed and precision. For example, in February 2025, DeepHealth, a US-based health informatics company, launched a new set of AI-powered radiology informatics and cancer screening solutions, which are supported by their cloud-native operating system, DeepHealth OS. This includes the Diagnostic Suite, a comprehensive AI-driven diagnostic workspace, along with sophisticated AI tools for screening lung, prostate, and brain health. These innovations are designed to bolster clinical accuracy, optimize workflows, and improve operational efficiency throughout diverse healthcare settings.

Who Are The Companies Operating Across The Medical Health Screening Market Value Chain?

Major companies operating in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc, Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc, DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc, Freenome Holdings Inc, Genova Diagnostics Inc, Cerba Healthcare SAS, DELFI Diagnostics Inc, Truvian Sciences Inc, ACM Medical Laboratory Inc, LabPlus, Sonic Healthcare Limited

Get The Full Medical Health Screening Market Report:

https://www.thebusinessresearchcompany.com/report/medical-health-screening-global-market-report

Which Region Is The Top Contributor To The Medical Health Screening Market By Share?

North America was the largest region in the medical health screening market in 2025. The regions covered in the medical health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Medical Health Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/medical-health-screening-global-market-report

Browse Through More Reports Similar to the Global Medical Health Screening Market 2026, By The Business Research Company

Pharmaceutical Glass Packaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-glass-packaging-global-market-report

Container Glass Market Report

https://www.thebusinessresearchcompany.com/report/container-glass-global-market-report

Sports Bottle Market Report

https://www.thebusinessresearchcompany.com/report/sports-bottle-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795